Duke Center for Cerebrovascular Disease |
The Duke Center for Cerebrovascular Disease was founded by Dr. Albert Heyman in 1966 as a collaborative effort of the NIH and the Veterans Administration. Initially housed in a small laboratory building donated by the VA, the center is now based in the Department of Medicine (Division of Neurology), and has expanded to develop affiliated programs and faculty from an extensive list of clinical departments, research laboratories and University centers. These include affiliations with the Duke Center for Clinical Health Policy Research, the Duke Clinical Research Institute, the Durham VA Institute for Clinical and Epidemiologic Research (see Affiliated Programs and Faculty for a complete listing). Research activities range from laboratory studies based on molecular biological approaches to neuropharmacology, neurophysiology, developmental neurobiology, receptor biology, cell biology and behavioral recovery. The affiliated Multidisciplinary Neuroprotection Laboratories are dedicated to studies focused on understanding the pathophysiology of stoke and acute brain injury and to developing novel treatments. A variety of clinically-based research projects are in progress including continuing participation in multicenter clinical trials. The Duke Center for Clinical Health Policy Research and the Durham VA Institute for Clinical and Epidemiologic Research have particular long-standing interests in stroke-related clinical health policy research. [Return to top of page]
![]() |
Duke University Hospital has world renowned facilities and faculty to support clinical care, clinical and laboratory based research in cerebrovascular disease. Duke Hospital is a tertiary care facility with over 1,000 beds. Independent clinical programs involved in the care of patients with cerebrovascular disease include faculty from Neurology, Anesthesiology, Cardiology, Diagnostic Ultrasonography, Hematology, Interventional Radiology, Neuroradiology, Neurosurgery, and Vascular Surgery. The latest diagnostic procedures including diffusion magnetic resonance imaging, CT angiography, and transcranial Doppler ultrasonography are available. [Return to top of page]
|
![]() |
State-of-the-art care of patients with acute stroke is provided through Duke’s Stroke Center, which has received a Certificate of Distinction as a Primary Stroke Center from the Joint Commission for the Accreditation of Healthcare Organizations (JCAHO). The Duke Stroke Center integrates the care of stroke patients from before Emergency Department arrival through in-patient care and assessments for rehabilitative services. Duke’s Acute Stroke Response Team is available for immediate patient evaluation and management. Patients who are not candidates for standard intravenous thrombolysis are routinely assessed for endovascular interventions. Several cutting-edge clinical trials evaluating new stroke treatments are always available (see Stroke-Related Clinical Research). Patients with acute stroke are routinely admitted to a 10 bed Stroke Acute Care Unit/ Neurosciences Stepdown Unit where specialized evaluation and treatment is available. Patients requiring higher levels of care are admitted to Duke’s adjacent 16 bed Neurosciences Intensive Care Unit. Duke also has 52 Neurosciences Intermediate Care beds for patients who require further evaluation and treatment after stabilization. The entire course of care is organized around critical pathways that facilitate the provision of multidisciplinary services. A multidisciplinary supervisory team continuously monitors the quality of stroke-related care. Outpatient consultative and diagnostic services for primary and secondary stroke preventive evaluations are available. [Return to top of page] |
![]() |
|
![]() |
Special conference was held August 22-23, 2005 Conference proceedings http://www.duke.edu/~bushn002/ |
For additional information concerning the Duke Center for Cerebrovascular Disease or the Duke Stroke Center, please write: